Favrille, Inc. To Host Conference Call And Live Webcast To Discuss Fourth Quarter And Year-End 2006 Financial Results On February 15, 2007

SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- Favrille, Inc. , a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced today that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, February 15, 2007 to discuss the Company's fourth quarter and year-end 2006 financial results. John P. Longenecker, Ph.D., President and Chief Executive Officer of Favrille, will also present an update on the Company. A press release reporting Favrille's fourth quarter and year-end financial results will be issued before the U.S. stock markets open on February 15, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)

A live audio webcast of management's presentation will be available on the Investor Relations section of the Company's web site at www.favrille.com. Alternatively, callers may participate in the conference call by dialing (800) 322-2803 or (617) 614-4925, passcode 22611527. A telephone replay of the call will also be available for 48 hours. The telephone replay can be accessed by dialing (888) 286-8010 or (617) 801-6888, passcode 83264040.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId, is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comFavrille, Inc.

CONTACT: Pete De Spain, Associate Director, Investor Relations & CorporateCommunications of Favrille, Inc., +1-858-526-2426, pdespain@favrille.com

Web site: http://www.favrille.com/